Potential new drug identified for inherited cancer
10/06/2013
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have identified a new drug candidate for an inherited form of cancer with no known cure. The new study showed the drug candidate - known as FRAX97 - slowed the proliferation and progression of tumor cells in animal models of Neurofibromatosis type 2...
Scientists Shed Light on Body's Master Energy Regulator
10/05/2013
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have discovered some key features that explain just what turns on a protein that is considered to be a master regulator of how the human body uses and stores energy...
Prostate cancer screenings: high Medicare spending but little benefit for older men
10/04/2013
Prostate cancer screening has little benefit for men aged 75 and older, yet over three years, the Medicare fee-for-service program spent $447 million annually on PSA-based screenings - one-third of which was for men in the over 75 age group, according to study by researchers at the Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center. Published in the Oct...
Prostate cancer screenings: high Medicare spending but little benefit for older men
10/04/2013
Prostate cancer screening has little benefit for men aged 75 and older, yet over three years, the Medicare fee-for-service program spent $447 million annually on PSA-based screenings - one-third of which was for men in the over 75 age group, according to study by researchers at the Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center. Published in the Oct...
NIH grant could develop technology to help personalize leukemia treatments
10/04/2013
People affected by leukemia and health care professionals who advocate for personalized medicine options could benefit from technology that is being developed with funding from a National Institutes of Health grant. Tymora Analytical Operations LLC, Purdue University and St. Jude Children's Research Hospital have been awarded a one-year, $300,000 Phase I STTR grant from the NIH...
Nottingham Hospitals in world first with Apple iPod blood-tracking
10/04/2013
Hospitals in Nottingham will become the first in the world to take advantage of an electronic blood-tracking system allowing nurses to use Apple iPods at the bedside. Nottingham University Hospitals NHS Trust has agreed the deal with leading healthcare technology company MSoft eSolutions to implement the technology at Nottingham City Hospital and Queen's Medical Centre...
Genetic anti-inflammatory defect predisposes children to lymphoma
10/04/2013
New research shows that children with an inherited genetic defect in a critical anti-inflammatory pathway have a genetic predisposition to lymphoma...
NIH grant could develop technology to help personalize leukemia treatments
10/04/2013
People affected by leukemia and health care professionals who advocate for personalized medicine options could benefit from technology that is being developed with funding from a National Institutes of Health grant. Tymora Analytical Operations LLC, Purdue University and St. Jude Children's Research Hospital have been awarded a one-year, $300,000 Phase I STTR grant from the NIH...
The landscape of medical oncology in Europe by 2020
10/04/2013
Many large European countries may be facing a future shortage of medical oncologists without realizing it--a situation that could have dire consequences for cancer patients, the European Society for Medical Oncology (ESMO) has warned...
Andrew Wilson of the Rarer Cancers Foundation expresses his support for the UK government's surprise announcement as health economists point to a change in direction for value-based pricing, and has said that the move could save up to 16,000 lives each year...